VARIPULSE catheter and TRUPULSE generator for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new catheter and generator system to treat persistent atrial fibrillation (an irregular heartbeat that lasts more than a week). It may help people whose symptoms haven't been controlled by medication and who need a procedure called ablation to fix the heart's electrical signals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with symptomatic persistent atrial fibrillation (a type of irregular heartbeat that doesn't stop on its own).
- You are scheduled to have a heart ablation procedure to treat your irregular heartbeat.
- You have tried at least one heart rhythm medication that didn't work or caused side effects.
- You are between 18 and 75 years old.
- You are willing to follow all study visits and requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests a new procedure called pulsed field ablation using a special catheter to treat paroxysmal atrial fibrillation (AF), a type of heart rhythm problem that comes and goes. It may be an option for people whose AF hasn't been controlled well with medication.
This study tests a new catheter to treat persistent atrial fibrillation (a type of irregular heartbeat lasting more than 7 days but less than a year). It aims to isolate the pulmonary veins and superior vena cava to restore normal rhythm. Some participants may also receive a left atrial appendage occlusion device if needed.
This study compares two different catheters that use pulsed field ablation to treat a type of irregular heartbeat called persistent atrial fibrillation. The goal is to see which one works better and is safer.
This study tests a new type of catheter (Varipulse) to treat paroxysmal atrial fibrillation (AFib that comes and goes) using a procedure done under sedation. It aims to see if the catheter is safe and effective for people whose symptoms aren't controlled by medication.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.